See also this year's filing and all EDGAR filings for this company.
PDF Report 0001818794_2021_Dyne_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001818794')"} |
Graph
Absolute values for 0001818794, Dyne Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 349,087,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 1,946,000 |
3 | remainder_Assets | 2,301,000 |
4 | LiabilitiesCurrent | 10,967,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 13,447,000 |
9 | ResearchAndDevelopmentExpense | 45,200,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -790,000 |
13 | remainder_ComprehensiveNetIncome | -27,000 |
yvar | yval | |
---|---|---|
0 | Assets | 353,334,000 |
1 | Liabilities | 10,967,000 |
2 | Expenses | 58,647,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 342,367,000 |
5 | NetIncome | -59,437,000 |
6 | ComprehensiveNetIncome | -59,450,500 |
7 | BaseVar | 211,882,500 |
8 | EconomicCapitalRatio | 2.91 |